Vertex Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2024 | VRTX
Vertex Pharmaceuticals total liabilities and share holders equity for the quarter ending June 30, 2024 was $20.132B, a 1.07% decline year-over-year.
- Vertex Pharmaceuticals total liabilities and share holders equity for 2023 was $22.73B, a 25.23% increase from 2022.
- Vertex Pharmaceuticals total liabilities and share holders equity for 2022 was $18.151B, a 35.13% increase from 2021.
- Vertex Pharmaceuticals total liabilities and share holders equity for 2021 was $13.433B, a 14.3% increase from 2020.